Managing Myelofibrosis for Patients Living Far From Specialists
https://vimeo.com/1001813824 Myelofibrosis expert Dr. Michael Grunwald from Levine Cancer Institute discusses strategies for patients living far away from specialists, how often blood checks should be performed, and proactive patient advice. [ACT]IVATION TIP…
Harnessing Community Resources to Support Rural Myelofibrosis Patients
https://vimeo.com/1001813005 How can community resources be utilized to support rural myelofibrosis patients? Expert Dr. Michael Grunwald from Levine Cancer Institute shares his perspective and how conversations with providers can be enriched. [ACT]IVATION…
Leveraging Telemedicine to Manage Myelofibrosis in Rural Areas | Overcoming Distance and Accessibility Challenges
https://vimeo.com/1001813133 How can telemedicine be leveraged to aid myelofibrosis patients in rural areas? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses methods used to help manage care of rural myelofibrosis patients,…
Helping Rural Doctors Recognize Myelofibrosis | How Patients and Providers Can Work Together
https://vimeo.com/1001812884 How can myelofibrosis patients and providers collaborate in helping rural doctors? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses common myelofibrosis symptoms and proactive patient advice for educating themselves and…
Barriers to Accessing Specialized Myelofibrosis Care in Rural Areas | Challenges and Solutions
https://vimeo.com/1001812407 What are common myelofibrosis care barriers in rural areas? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses barriers that myelofibrosis patients in rural areas encounter and solutions for overcoming barriers…
Novel Therapies and Clinical Trials for Myelofibrosis | Updates and Innovations
https://vimeo.com/1001812578 What’s the latest in higher risk myelofibrosis novel therapies and clinical trials? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses JAK inhibitors and other research updates along with proactive patient…
How Does Risk Stratification Shape Myelofibrosis Treatment?
https://vimeo.com/1000239081 What is involved in determining low risk versus high risk myelofibrosis? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses IPSS, DIPSS, MYSEC-PM, and MIPSS70 scoring systems, key patient factors they…
[ACT]IVATED Myelofibrosis Resource Guide en español
Descargar Guía Download Guide | Descargar Guía See More From [ACT]IVATED Myelofibrosis Share Your Feedback
[ACT]IVATED Myelofibrosis Resource Guide
Download Guide Download Guide | Descargar Guía See More From [ACT]IVATED Myelofibrosis Share Your Feedback
Considering a Myelofibrosis Clinical Trial? Questions You Should Ask
https://vimeo.com/928809660 What questions should patients ask when considering a myelofibrosis clinical trial? Expert Dr. Gabriela Hobbs discusses how clinical trials may fit into a treatment plan and shares key questions…
What Are the Currently Approved Myelofibrosis Therapies?
https://vimeo.com/928808656 Expert Dr. Gabriela Hobbs shares an overview of available therapies and important considerations when choosing a myelofibrosis treatment plan. Dr. Gabriela Hobbs is a hematology-oncology physician specializing in the…
Myelofibrosis Clinical Trial Participation | How Does It Move Research Forward?
https://vimeo.com/928808368 How do clinical trials move myelofibrosis research forward? Expert Dr. Gabriela Hobbs discusses the purpose of clinical trials, factors that may impact participation, and how trials can benefit patients….